Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors

doi:10.3748/wjg.v21.i27.8271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 27

This Article

(342)

(448)

(0)

(8557)

(36)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Gastroenterol. Jul 21, 2015; 21(27): 8271-8283
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8271

Table 2 Cholangiocarcinoma studies n (%)

Author	Type of microsphere	Type of mets (patients)	Response criteria	Response	Median OS
(publish date and study type)	(average dosage or activity)	Type of mets (patients)	@ 1^st assessment	Response	Median OS
Ibrahim et al[69]	Therasphere	ICC (24)	WHO	6 (27) PR	14.9 mo
(10/2008, PC)	(median 105.1 Gy)		@ 1 mo	15 (68) SD
				1 (5) PD	31.8 mo (solitary)
				2 lost	6.1 mo (extrahepatic disease)
Saxena et al[71]	SIR-Spheres	ICC (25)	RECIST	6 (26) PR	9.3 mo
(2/2010, PC)	(mean 1.76 Gbq)		@ 8.1 mo (median)	11 (48) SD
				5 (22) PD
				2 lost
Haug et al[68]	SIR-Spheres	ICC (26)	RECIST	5 (22) PR	11.7 mo
(6/2011, PC)	(no dosage info)		@ 2.8 mo	15 (65) SD
				3 (13) PD
				3 lost
Hoffmann et al[3]	SIR-Spheres	ICC (33)	RECIST	12 (36) PR	22 mo
(2/2012, RS)	(median 1.54 Gbq)		@ 3 mo	17 (52) SD
				4 (12) PD
Rafi et al[70]	SIR-Spheres	ICC (19)	RECIST	2 (11) PR	11.5 mo
(4/2013, PC)	(mean 1.20 Gbq)		@ 3 mo	13 (68) SD
				4 (21) PD
Mouli et al[74]	Therasphere	ICC (46)	WHO	11 (25) PR	No median OS
(8/2013, PC)	(no dose info)	Note: overlaps with Ibrahim et al	@ 1 mo	33 (73) SD 1 (2) PD	14.6 mo (solitary) 5.7 mo (multifocal)
Camacho et al[72]	SIR-Spheres	ICC (21)	RECIST	RECIST	16.3 mo
(2/2014, PC)	(no dose info)		mRECIST	1 (4.7) PR
			EASL	16 (76.2) SD
			@ 1 mo	4 (19.1) PD
				mRECIST
				13 (62.0) PR
				4 (19.0) SD
				4 (19.0) PD
				EASL
				2 (9.5) PR
				15 (71.4) SD
				4 (19.1) PD
Filippi et al[73]	SIR-Spheres	ICC (18)	PERCIST	14 (82.3) PR	14.8 mo
(8/2014, PC)	(not given)	ICC (18)	@ unspecified	3 (17.6) SD	14.8 mo

ICC: Intrahepatic cholangiocarcinoma; PC: Prospective cohort study; RS: Retrospective study; CR: Complete response; PR: Progressive response; PD: Progressive disease; SD: Stable disease; OS: Overall survival; OR: Overall response.

Full Size Table

Citation: Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283
URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8271.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8271

Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283 [PMID: 26217079 DOI: 10.3748/wjg.v21.i27.8271]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.